Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 27% ± 7% | |
| endothelial cell | 4 studies | 17% ± 1% | |
| astrocyte | 4 studies | 24% ± 5% | |
| B cell | 3 studies | 19% ± 2% | |
| ciliated cell | 3 studies | 18% ± 1% | |
| GABAergic neuron | 3 studies | 33% ± 5% | |
| glutamatergic neuron | 3 studies | 39% ± 8% | |
| transit amplifying cell | 3 studies | 25% ± 6% | |
| oligodendrocyte | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3125.77 | 1445 / 1445 | 100% | 8.60 | 183 / 183 |
| pancreas | 100% | 3099.96 | 328 / 328 | 100% | 9.92 | 178 / 178 |
| prostate | 100% | 5450.01 | 245 / 245 | 100% | 18.50 | 502 / 502 |
| thymus | 100% | 5807.34 | 653 / 653 | 100% | 16.95 | 605 / 605 |
| brain | 100% | 3518.22 | 2641 / 2642 | 100% | 17.23 | 705 / 705 |
| breast | 100% | 3188.61 | 459 / 459 | 100% | 10.14 | 1117 / 1118 |
| bladder | 100% | 3471.95 | 21 / 21 | 100% | 10.51 | 503 / 504 |
| uterus | 100% | 4564.90 | 170 / 170 | 100% | 11.70 | 458 / 459 |
| skin | 100% | 3345.22 | 1809 / 1809 | 100% | 11.10 | 470 / 472 |
| lung | 100% | 3037.15 | 577 / 578 | 100% | 9.58 | 1152 / 1155 |
| adrenal gland | 100% | 2384.91 | 258 / 258 | 100% | 10.89 | 229 / 230 |
| ovary | 100% | 5758.42 | 180 / 180 | 100% | 9.35 | 428 / 430 |
| intestine | 100% | 3346.32 | 966 / 966 | 99% | 11.50 | 524 / 527 |
| liver | 100% | 2045.65 | 225 / 226 | 100% | 7.53 | 405 / 406 |
| kidney | 100% | 3056.71 | 89 / 89 | 99% | 7.84 | 893 / 901 |
| stomach | 100% | 2993.01 | 359 / 359 | 99% | 9.64 | 282 / 286 |
| adipose | 100% | 2848.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 12.29 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 13.51 | 29 / 29 |
| spleen | 100% | 3728.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 10.46 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.86 | 1 / 1 |
| blood vessel | 100% | 2941.29 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1973.19 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 1842.91 | 849 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 69% | 1068.96 | 638 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1903706 | Biological process | regulation of hemopoiesis |
| GO_0097190 | Biological process | apoptotic signaling pathway |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
| GO_0001558 | Biological process | regulation of cell growth |
| GO_0140889 | Biological process | DNA replication-dependent chromatin disassembly |
| GO_0048144 | Biological process | fibroblast proliferation |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_2000278 | Biological process | regulation of DNA biosynthetic process |
| GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
| GO_0006473 | Biological process | protein acetylation |
| GO_0006275 | Biological process | regulation of DNA replication |
| GO_0045926 | Biological process | negative regulation of growth |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0050793 | Biological process | regulation of developmental process |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0070776 | Cellular component | MOZ/MORF histone acetyltransferase complex |
| GO_0000123 | Cellular component | histone acetyltransferase complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0035064 | Molecular function | methylated histone binding |
| GO_0003682 | Molecular function | chromatin binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ING5 |
| Protein name | Inhibitor of growth family member 5 Inhibitor of growth protein 5 (p28ING5) |
| Synonyms | |
| Description | FUNCTION: Component of the HBO1 complex, which specifically mediates acetylation of histone H3 at 'Lys-14' (H3K14ac) and, to a lower extent, acetylation of histone H4 . Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity . Through chromatin acetylation it may regulate DNA replication and may function as a transcriptional coactivator . Inhibits cell growth, induces a delay in S-phase progression and enhances Fas-induced apoptosis in an INCA1-dependent manner . . |
| Accessions | A0A1B0GW41 E9PEN0 ENST00000636051.1 ENST00000445620.5 Q8WYH8 ENST00000406941.5 [Q8WYH8-2] ENST00000313552.11 [Q8WYH8-1] |